跳至主要内容
临床试验/JPRN-UMIN000041916
JPRN-UMIN000041916已完成未知

Pneumonitis in the combination therapy of immune checkpoint inhibitors and chemotherapy: a meta-analysis of phase 3 randomized clinical trials - Pneumonitis in the combination therapy with immune checkpoint inhibitors: Insights from a meta-analysis

Icahn School of Medicine at Mount Sinai, Mount Sinai Beth Israel Department of Medicine0 个研究点目标入组 15,006 人开始时间: 2020年9月28日最近更新:

试验速览

阶段
未知
状态
已完成
发起方
入组人数
15,006

研究概览

简要总结

Please see: Eur J Cancer. 2021 Jun;150:168-178. doi: 10.1016/j.ejca.2021.03.012.

研究设计

研究类型
Others,meta-analysis etc

入排标准

年龄范围
18years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • (1) Systematic review or meta-analysis articles. (2) Retrospective analysis. (3) Single prospective cohort study without a control group. (4) Non-RCT. (5) The republished research literature is excluded unless the research includes new findings related to adverse events listed in inclusion criteria. (6) Studies with no or insufficient safety results at the time of the literature search. (7) Studies published in languages other than English.

研究者

发起方
Icahn School of Medicine at Mount Sinai, Mount Sinai Beth Israel Department of Medicine

相似试验